HELX vs. LVHD
HELX (Franklin Genomic Advancements ETF) and LVHD (Legg Mason Low Volatility High Dividend ETF) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while LVHD is a Volatility Hedged Equity fund tracking the QS Low Volatility High Dividend Index. HELX is actively managed, while LVHD is passively managed. Over the past 5 years, HELX returned -4.45%/yr vs 6.47%/yr for LVHD. At a 0.34 correlation, their price movements are largely independent. HELX charges 0.50%/yr vs 0.27%/yr for LVHD.
Performance
HELX vs. LVHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a -4.15% return, which is significantly lower than LVHD's 8.83% return.
HELX
- 1D
- -2.64%
- 1M
- 0.97%
- YTD
- -4.15%
- 6M
- -6.12%
- 1Y
- 31.33%
- 3Y*
- 4.41%
- 5Y*
- -4.45%
- 10Y*
- —
LVHD
- 1D
- 1.47%
- 1M
- 0.76%
- YTD
- 8.83%
- 6M
- 9.15%
- 1Y
- 12.66%
- 3Y*
- 9.98%
- 5Y*
- 6.47%
- 10Y*
- 8.20%
HELX vs. LVHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | -4.15% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
LVHD Legg Mason Low Volatility High Dividend ETF | 8.83% | 7.50% | 10.18% | -0.95% | -1.82% | 26.90% | 8.08% |
Correlation
The correlation between HELX and LVHD is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.34 |
The correlation between HELX and LVHD shifts across timeframes, from 0.18 (1 year) to 0.41 (5 years), reflecting how their relationship changes across market environments.
HELX vs. LVHD - Sectors Allocation Comparison
Sectors
HELX
LVHD
Healthcare
Basic Materials
-
Technology
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Utilities
-
Healthcare
HELX
LVHD
Basic Materials
HELX
LVHD
-
Technology
HELX
LVHD
Communication Services
HELX
-
LVHD
Consumer Cyclical
HELX
-
LVHD
Consumer Defensive
HELX
-
LVHD
Energy
HELX
-
LVHD
Financial Services
HELX
-
LVHD
Industrials
HELX
-
LVHD
Real Estate
HELX
-
LVHD
Utilities
HELX
-
LVHD
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. LVHD — Risk / Return Rank
HELX
LVHD
HELX vs. LVHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Legg Mason Low Volatility High Dividend ETF (LVHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELX | LVHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.16 | ||
| Sortino ratioReturn per unit of downside risk | +0.19 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.23 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.75 | 2.06 | -0.31 |
| Martin ratioReturn relative to average drawdown | 4.51 | 5.20 | -0.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELX | LVHD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.48 | 1.32 | +0.16 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.18 | 0.50 | -0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.53 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.58 | -0.35 |
Drawdowns
HELX vs. LVHD - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than LVHD's maximum drawdown of -37.32%. Use the drawdown chart below to compare losses from any high point for HELX and LVHD.
Loading charts...
Drawdown Indicators
| HELX | LVHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -37.32% | -21.43% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -6.17% | -11.84% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -14.29% | -15.19% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -16.75% | -42.00% |
Max Drawdown (10Y)Largest decline over 10 years | — | -37.32% | — |
Current DrawdownCurrent decline from peak | -39.86% | -2.96% | -36.90% |
Average DrawdownAverage peak-to-trough decline | -34.32% | -4.05% | -30.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.97% | 2.44% | +4.53% |
Volatility
HELX vs. LVHD - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) has a higher volatility of 7.78% compared to Legg Mason Low Volatility High Dividend ETF (LVHD) at 3.23%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than LVHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | LVHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.78% | 3.23% | +4.55% |
Volatility (6M)Calculated over the trailing 6-month period | 16.67% | 6.76% | +9.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.23% | 9.61% | +11.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.17% | 12.88% | +11.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.42% | 15.51% | +11.91% |
HELX vs. LVHD - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is higher than LVHD's 0.27% expense ratio.
Dividends
HELX vs. LVHD - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.41%, less than LVHD's 3.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 0.41% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% |
LVHD Legg Mason Low Volatility High Dividend ETF | 3.34% | 3.35% | 4.23% | 3.55% | 3.30% | 2.56% | 3.27% | 3.30% | 3.82% | 3.33% | 2.48% |
Frequently Asked Questions
HELX and LVHD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (7.78%) compared to LVHD (3.23%). In terms of maximum drawdown, HELX dropped -58.75% vs LVHD's -37.32%.
On 5-year performance, LVHD leads with 6.47% vs -4.45% for HELX. On fees, LVHD is cheaper at 0.27% per year. On volatility, LVHD has been the lower-risk option at 3.23%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, LVHD has performed better with a 6.47% return vs -4.45%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
LVHD is cheaper with a 0.27% expense ratio, compared with 0.50% for HELX.
LVHD has the higher dividend yield at 3.34%, compared with 0.41% for HELX.
HELX is categorized as Health & Biotech Equities, while LVHD is Volatility Hedged Equity. Their fees differ too: 0.50% for HELX and 0.27% for LVHD.
HELX currently has the higher Sharpe Ratio (1.48 vs 1.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and LVHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer